Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00686205 · ClinicalTrials.gov registry record · Phase 3
Evaluation of a Human Immunodeficiency Virus (HIV) Blood Screening Assay
A Phase 3 study, sponsored by Abbott Diagnostics Division.
- Completed
- Registry status
- Phase 3
- Development phase
- 24,111
- Enrollment target
NCT00686205: Completed Phase 3 study, sponsored by Abbott Diagnostics Division.
NCT00686205 is a Phase 3 study that has completed, run by Abbott Diagnostics Division. The registered enrollment target is 24,111 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00686205, a Phase 3 study, has completed, sponsored by Abbott Diagnostics Division.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 24,111 participants
- Enrollment target
Study Summary
To test blood samples from volunteer donors of whole blood and blood components using a new investigational test that detects human immunodeficiency virus (HIV) infection. Results will be compared to the current HIV screening assay.
Interventions
- DEVICE collection of follow-up sample based on PRISM HIV O Plus result
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24,111 participants |
| Start Date | 2007-08 |
| Est. Completion | 2008-08 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00686205
The ClinicalTrials.gov registry entry for NCT00686205 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 24,111 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Abbott Diagnostics Division, which has 7 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which collection of follow-up sample based on PRISM HIV O Plus result is the first listed.
NCT00686205 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00686205 about?
NCT00686205 is a clinical study titled "Evaluation of a Human Immunodeficiency Virus (HIV) Blood Screening Assay". To test blood samples from volunteer donors of whole blood and blood components using a new investigational test that detects human immunodeficiency virus (HIV) infection. Results will be compared to the current HIV screening assay.
What is the current status of trial NCT00686205?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 24,111 participants. The study started on 2007-08. Estimated completion is 2008-08.
What interventions are being tested in trial NCT00686205?
The interventions under investigation include: collection of follow-up sample based on PRISM HIV O Plus result (DEVICE).
Who is sponsoring clinical trial NCT00686205?
This trial is sponsored by Abbott Diagnostics Division, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.